PA
QTRX icon

PharVision Advisers’s Quanterix QTRX Stock Holding History

PharVision Advisers’s Portfolio QTRX Stock Details QTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.3K Buy
+13,039
New +$42.3K 1.06% 57
2025
Q4 		– Sell
-36,144
Closed -$196K – 946
2025
Q3 		$196K Buy
+36,144
New +$192K 0.11% 523

Other funds holding QTRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lionhunter Capital Management New York $222M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PharVision Advisers's QTRX Position: Q2 2026 in Review

PharVision Advisers opened a new position in Quanterix (QTRX) in Q2 2026: 13,039 shares worth $56.3K. The stake represents 1.06% of the portfolio and ranks #57 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in QTRX as recently as Q3 2025.

PharVision Advisers first reported a position in QTRX in Q3 2025 and has held it in 2 quarters since. The position peaked at $196K in Q3 2025. 132 funds tracked by Wall St. Rank hold QTRX as of Q2 2026.

  • PharVision Advisers held 13,039 shares of Quanterix worth $56.3K as of Q2 2026.
  • Quanterix was a new PharVision Advisers position in Q2 2026.
  • Quanterix made up 1.06% of PharVision Advisers's portfolio in Q2 2026, its #57 holding.
  • PharVision Advisers first reported a position in Quanterix in Q3 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Quanterix position peaked at $196K in Q3 2025.
  • 132 funds tracked by Wall St. Rank held Quanterix as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.